CLÀUDIA COLL MARTINEZ

CLÀUDIA COLL MARTINEZ is a pre-doctoral researcher (R1) focused on neurodegenerative and neuroinflammatory processes, particularly in multiple sclerosis (MS). Her work bridges clinical research with translational science, emphasizing biomarker discovery and cognitive rehabilitation programs. She collaborates on projects funded by institutions like the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA.

Her research interests include:

• Cognitive impairment mechanisms in MS
• Biomarker development for neurodegenerative processes
• Gut-brain axis interactions
• Obesity's impact on neurocognitive functions
• Imaging techniques for disease tracking

Key projects include the MS-LINE! cognitive rehabilitation program and EM-Line!Kids pediatric rehabilitation initiative. Recent work explores cytokine profiles, microRNA markers, and microbiota influences on brain function. She has published extensively in journals like Frontiers in Neurology and Multiple Sclerosis Journal.

Notable contributions focus on:

• Interleukin-6/8 biomarker potential for cognitive outcomes
• IVIM MRI metrics for obesity-related brain perfusion
• Blastocystis microbiota's cognitive effects

Current affiliations involve collaborative work in neuroimaging and nutritional health research groups. She actively participates in multidisciplinary teams addressing both clinical and basic neuroscience questions.